The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Clinical correlates of blood serotonin levels in patients with mastocytosis
Open accessAbstract
BACKGROUND: Mastocytosis is a clonal disorder associated with an increased mast cell burden. We have recently demonstrated the ability of human mast cells to express and be activated through multiple serotonin receptors; to synthesize and release serotonin; and that mastocytosis patients may have abnormal serotonin levels. As serotonin has been implicated in the genesis of clinical symptoms found in association with some chronic diseases, we have now determined the whole blood serotonin levels in 29 patients diagnosed with mastocytosis, and correlated these levels with multiple clinical and laboratory parameters. MATERIALS AND METHODS: Patients with mastocytosis were categorized according to disease variant. Blood serotonin values were determined and correlated with values reported for normal subjects; and clinical and laboratory features of the disease. RESULTS: Total blood serotonin levels followed a bimodal distribution in line with our earlier report, unlike the normal distribution reported for normal individuals. Serotonin levels did not correlate with platelet numbers, liver function tests or serum tryptase levels. Patients with lower serotonin values had greater rates of fatigue (P = 0.0001), migraine headaches (P = 0.0028), psychiatric symptoms (P = 0.0001), diarrhoea (P = 0.0407), flushing (0.0085), and abdominal and bone pain (P = 0.0001). CONCLUSIONS: Our study suggests that low blood serotonin levels help define a sub-group of patients with mastocytosis that are more likely to present with neurological and gastrointestinal complaints, and suggests that the use of pharmacologic agents that alter blood serotonin levels could be explored in selected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there are insuf fi cient data to demonstrate their clinical utility in the diagnosis of MCA and MCAS.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationAnaphylaxis: Lessons from mouse models
Finkelman, F. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.033 · Cited by 404
New pathophysiological mechanisms in irritable bowel syndrome
Barbara, G., GIORGIO, R. D., Stanghellini, V., Cremon, C., Salvioli, B., & Corinaldesi, R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02036.x · Cited by 226
Humphrey, P. P. A., Feniuk, W., Perren, M. J., Beresford, I. J. M., Skingle, M., & Whalley, E. T. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16912.x · Cited by 225
Akin, C., & Metcalfe, D. D. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103822 · Cited by 215
Self-citationHuman mast cells are capable of serotonin synthesis and release
Kushnir‐Sukhov, N. M., Brown, J. M., Wu, Y., Kirshenbaum, A. S., & Metcalfe, D. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.003 · Cited by 194
Self-citationA Case of Intestinal Mastocytosis Misdiagnosed as Crohn's Disease
Reggiani, S., Cosso, L., Adriani, A., Pantaleoni, S., Risso, A., Vittone, F., Chiusa, L., Sapone, N., & Astegiano, M. (2015) · Case Reports in Gastroenterology · doi:10.1159/000430946 · Cited by 193
5-Hydroxytryptamine Induces Mast Cell Adhesion and Migration
Kushnir‐Sukhov, N. M., Gilfillan, A. M., Coleman, J. W., Brown, J. M., Bruening, S., Tóth, M., & Metcalfe, D. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6422 · Cited by 151
Self-citationCurrent concepts of migraine pathogenesis.
Lance, J. W. (1993) · PubMed · Cited by 128
Schwartz, L. B., Min, H.-K., Ren, S., Xia, H.-Z., Hu, J., Zhao, W., Moxley, G., & Fukuoka, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5667 · Cited by 120
Research works printed but not linked: 2
- Arnekio‐Nobin B, 1988, Effect of long‐term ketanserin treatment on 5‐HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double‐blind, placebo‐controlled cross‐over study, Int Angiol, 7, 19
- Valent P, 2001, Tumours of Haematopoietic and Lymphoid Tissues, 291
Cited by
Sorted by citations
Serotonin signalling in the gut: functions, dysfunctions and therapeutic targets
Mawe, G. M., & Hoffman, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.105 · Cited by 1,165
Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management
Castells, M., & Butterfield, J. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.02.002 · Cited by 135
Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
“Other potential markers that have been discussed in the context of MCA include heparin, serotonin, neuropeptides, platelet-activating factor, and chromogranin A (CgA).(13,71-76) However, there are insufficient data to demonstrate their clinical utility in the diagnosis of MCA and MCAS.”
BackgroundSelf-citationVysniauskaite, M., Hertfelder, H.-J., Oldenburg, J., Dreßen, P., Brettner, S., Homann, J., & Molderings, G. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124912 · Cited by 30
Divekar, R., & Butterfield, J. (2015) · Allergy · doi:10.1111/all.12668 · Cited by 27
Metadata
- Authors
- Kushnir‐Sukhov, N. M., Brittain, E., Scott, L., & Metcalfe, D. D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Metcalfe, D. D.
- ORCID
- Brittain, E.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2008-11-19
- Volume
- 38
- Issue
- 12
- Pages
- 953-958
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- PMC
- PMC3795418
- OpenAlex
- W2069908120
- Cited by
- 40
- References
- 29
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 3 · 2016: 4 · 2015: 8 · 2014: 1 · 2013: 4 · 2012: 1
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI000249)
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- mastocytosis, blood serotonin, serotonin receptors, mast cells, fatigue, migraine, psychiatric symptoms, diarrhea, flushing, abdominal pain, bone pain, tryptase, disease variants
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Platelets, Female, Humans, Male, Mast Cells, Mastocytosis, Middle Aged, Serotonin, Tryptases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
